FeedsFarm.com > Market Pulse: Novartis to buy 19.9% stake in Alnylam Pharmaceuticals

Source:

Financial News News from myHealthcareNews.com

Language:

English

Domain:

www.myhealthcarenews.com

More feeds from myhealthcarenews.com:

• Bio-Technology News from StratCenter.com
• Distribution/ Logistics News from StratCenter.com
• FDA News News from StratCenter.com
• Information Technologies/ MIS/ HIS News from StratCenter.com
• Magnetic Resonance Imaging (MRI) News from StratCenter.com
• Orthopedics News from StratCenter.com
• Pacemakers News from StratCenter.com
• Patient Monitoring News from StratCenter.com
• Physician News News from StratCenter.com
• Pulmonary/ Respiratory News from StratCenter.com

Search myhealthcarenews.com:

Market Pulse: Novartis to buy 19.9% stake in Alnylam Pharmaceuticals

7th Sep 2005, 11:47 GMT

Novartis and Alnylam Pharmaceuticals will team on a multiyear alliance in which they will focus on discovering therapeutics based on RNAi.

Latest news from Financial News News from myHealthcareNews.com:

• TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
• Bio-Rad Closes Buy of Ciphergen Unit
• The LGL Group Reports Q3 Earnings
• Analogic CEO to retire
• Analogic CEO Plans to Retire
• Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
• JMAR Receives Nasdaq Delisting Notice
• Analogic Corp Announces Mgmt Changes
• Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
• Agilent to buy Switzerland's Acqiris